Ahmed A. Arif

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 589 citations · Full text

Urology, Renal Disease, Renal Events +7

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Stefano Del Prato, Steven E. Kahn, Imre Pávó et al. · The Lancet · 2021 · 586 citations

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 298 citations

Asthma, Rheumatology, Extension Trial +10

Patterns of alcohol drinking and its association with obesity: data from the third national health and nutrition examination survey, 1988–1994

Ahmed A. Arif, James E. Rohrer · BMC Public Health · 2005 · 228 citations · Full text

Prevalence and risk factors of asthma and wheezing among US adults: an analysis of the NHANES III data

Ahmed A. Arif, George L. Delclos, E.S. Lee et al. · European Respiratory Journal · 2003 · 199 citations · Full text

Asthma, Environmental Allergy, Pet Ownership +15